Taevas
Sri LankaPharmaceuticals
Product Registration
Market Access for Product-Registration in Sri Lanka
Navigating the complex global landscape of product registration requires a robust market access strategy. Taevas Life Sciences provides comprehensive solutions to ensure your innovative therapies reach patients worldwide efficiently and effectively, secur
Market
Global
Industry
Product-Registration
Regulator
International Regulatory Bodies
Timeline
8-12 weeks (initial strategy)
Deliverables
Strategic Report, Implementation Roadmap, Value Dossier
What We Deliver
6 Pillars of Market Access for Global Product Registration
Every engagement covers a structured set of pillars — each customised to your specific category, target segment, and strategic questions.
01
Global Regulatory Intelligence & Strategy
We provide in-depth analysis of diverse regulatory requirements across target markets, developing a cohesive strategy that anticipates challenges and streamlines registration pathways.
Horizon Scanning for Emerging Regulations
Jurisdiction-Specific Regulatory Pathway Mapping
How It Works
How Our Global Market Access Process Works
A structured engagement — typically delivered in a few weeks.
Step 1 · Week 1-2
Discovery & Landscape Analysis
We begin with a thorough assessment of your product, target markets, and existing data, coupled with a deep dive into the global regulatory and market access landscape relevant to your therapy area.
Market Snapshot
Market Overview: Global + Product-Registration
Increasing Regulatory Divergence
The growing complexity and divergence of regulatory requirements across major and emerging markets necessitate a nuanced, region-specific approach to product registration and market access.
Heightened Payer Scrutiny
Global payers are increasingly demanding robust real-world evidence and compelling economic value propositions, making early HTA and reimbursement planning critical for successful market entry.
Value-Based Access Models
The shift towards value-based healthcare models globally requires innovative market access strategies that demonstrate long-term patient outcomes and cost-effectiveness beyond initial approval.
What's Included
Deliverables
A structured, decision-ready package of deliverables.
Global Market Access Strategy Report
A comprehensive document outlining strategic pathways, timelines, and key considerations for market entry across target geographies.
Tailored Global Value Dossier (GVD)
A robust, evidence-backed dossier articulating your product's clinical and economic value for adaptation to local payer requirements.
Reimbursement & Pricing Strategy Blueprint
Detailed recommendations for optimal pricing and reimbursement approaches, considering local market dynamics and payer landscapes.
Regulatory Compliance & Submission Roadmap
A clear plan detailing all necessary regulatory submissions, timelines, and compliance requirements for global product registration.
Who This Is For
Use Cases
Biotech Startup
First Global Launch of an Orphan Drug
A biotech company with a novel orphan drug needed to navigate complex and varied regulatory and reimbursement pathways across North America, Europe, and Asia for its first global launch.
Outcome
Taevas developed a multi-region market access strategy, leading to accelerated approvals and favorable reimbursement decisions in key markets.
Next Steps
Related Services
FAQ
Frequently Asked Questions
Get Started
Ready to Start Market Access in Global?
Partner with Taevas Life Sciences to transform your product registration into a pathway for sustained global market success and patient access.
Access Expert Global Market Insights
Streamline Your Regulatory Journey
Optimize Reimbursement & Pricing
Achieve Faster, Broader Market Entry